Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Clinical Chemistry 46: 258-264, 2000;
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (16)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Yu, H. H.
Right arrow Articles by Rifai, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Yu, H. H.
Right arrow Articles by Rifai, N.
Related Collections
Right arrow Nutrition
Right arrow Endocrinology and Metabolism
Right arrow Automation and Analytical Techniques
(Clinical Chemistry. 2000;46:258-264.)
© 2000 American Association for Clinical Chemistry, Inc.

Articles

Agreement among Four Homocysteine Assays and Results in Patients with Coronary Atherosclerosis and Controls

Harry H. Yu1, Rana Joubran2, Muhamad Asmi3, Terence Law1, Anthony Spencer1, Muhidien Jouma4 and Nader Rifai1,a

1 Departments of Laboratory Medicine and Pathology, Children’s Hospital, Harvard Medical School, Boston, MA 02115.
Departments of
2 Clinical Laboratories and
3 Cardiology, University of Damascus Hospitals, Damascus, Syria.

4 Department of Biochemistry and Microbiology, School of Pharmacy, University of Damascus, Damascus, Syria.
a Address correspondence to this author at: Children’s Hospital, Department of Laboratory Medicine, 300 Longwood Ave., Boston, MA 02115. E-mail rifai{at}a1.tch.harvard.edu

Background: Hyperhomocysteinemia has been associated with coronary atherosclerosis in many, but not all, prospective and retrospective studies. Some on these inconsistencies may be attributed to methodological variabilities.

Methods: In the present study, three newly commercially available assays and one in-house HPLC assay for total homocysteine (tHcy) were utilized in 99 subjects with angiographically documented atherosclerosis and in 91 community controls matched by age, gender, and smoking history. The in-house assay, a modified Fortin and Genest HPLC method, was compared with the Bio-Rad HPLC assay, the Abbott IMx® fluorescence polarization immunoassay, and a Bio-Rad enzyme-linked immunoassay (EIA) microtiter method.

Results: Correlation coefficient values between the in-house HPLC assay and the Bio-Rad HPLC, the Abbott IMx, and the Bio-Rad EIA assays were 0.95, 0.96 and 0.90, respectively. Although tHcy concentrations were higher in cases compared with controls by all four methods, the difference reached statistical significance only with the in-house HPLC procedure (median, 13.5 ± 6.7 µmol/L in cases vs 10.9 ± 4.8 µmol/L in controls; P <0.01, adjusting for covariates), where it was an independent predictor of case or control status, along with hypertension, total cholesterol, and triglycerides. The tHcy distributions in cases and controls demonstrated significant overlap. The number of atherosclerotic major coronary vessels was associated with significantly higher tHcy (P <0.01 for trend) in all four methods.

Conclusions: The three commercial assays for tHcy differed in analytical and clinical performance. Analytically, the Abbott IMx method showed the best comparability with the in-house assay, but clinically, the three commercial methods were similar and did not distinguish cases from controls.




The following articles in journals at HighWire Press have cited this article:


Home page
 Clin. Chem.Home page
R. Obeid, M. Jouma, and W. Herrmann
Cobalamin Status (Holo-Transcobalamin, Methylmalonic Acid) and Folate as Determinants of Homocysteine Concentration
Clin. Chem., November 1, 2002; 48(11): 2064 - 2065.
[Full Text] [PDF]

Home page
 CirculationHome page
C. M. Albert, J. Ma, N. Rifai, M. J. Stampfer, and P. M. Ridker
Prospective Study of C-Reactive Protein, Homocysteine, and Plasma Lipid Levels as Predictors of Sudden Cardiac Death
Circulation, June 4, 2002; 105(22): 2595 - 2599.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
G. L. Hortin, P. Sullivan, and G. Csako
Relationships among Plasma Homocysteine, Cysteine, and Albumin Concentrations: Potential Utility of Assessing the Cysteine/Homocysteine Ratio
Clin. Chem., June 1, 2001; 47(6): 1121 - 1124.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2000 by the American Association for Clinical Chemistry.